1-2 of 2
Maria Luisa Martin, PhD
Close
Sort by
Journal Articles

Double Vs Single Autologous Stem Cell Transplantation After Bortezomib-Based Induction Regimens For Multiple Myeloma: An Integrated Analysis Of Patient-Level Data From Phase European III Studies

Michele Cavo, MD, Hans Salwender, MD, Laura Rosiñol, MD, Philippe Moreau, MD, Maria Teresa Petrucci, MD, Igor Wolgang Blau, MD, Joan Bladé, MD, PhD, Michel Attal, MD, Francesca Patriarca, MD, Katja Weisel, MD, Jesus F San Miguel, MD, PhD, Herve Avet-Loiseau, MD, Nicoletta Testoni, BS, Michael Pfreundschuh, Prof MD, Juan Jose Lahuerta, MD, Thierry Facon, MD, Lucia Pantani, MD, Christof Scheid, MD, Norma Gutierrez, PhD, MD, Gerald Marit, MD, Antonio Palumbo, MD, Maria Luisa Martin, PhD, Denis Caillot, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2013) 122 (21): 767.
https://doi.org/10.1182/blood.V122.21.767.767
Published: 2013
Journal Articles

Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies

Michele Cavo, MD, Pieter Sonneveld, MD, Philippe Moreau, MD, Joan Bladè, MD, Hartmut Goldschmidt, MD, Jesús F San Miguel, MD, Michel Attal, MD, Hervé Avet-Loiseau, MD, PhD, Wolgang Igor Blau, MD, Thierry Facon, MD, Norma Gutierrez, Jean-Luc Harousseau, MD, Bronno van der Holt, Juan Jose Lahuerta, MD, Henk Lokhorst, MD, Gerald Marit, MD, Maria Luisa Martin, PhD, Giulia Marzocchi, PhD, Antonio Palumbo, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, MD, Laura Rosiñol, MD, Hans Salwender, MD, Carolina Terragna, PhD
Journal: Blood
Blood (2012) 120 (21): 749.
https://doi.org/10.1182/blood.V120.21.749.749
Published: 2012